ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Fungal infection"

  • 2018 American Transplant Congress

    Tacrolimus and Isavuconazole Therapy: What about the Drug Interaction?

    C. Gill,1 N. Mercuro,1 R. Kenney,1 A. Jantz,1 B. Summers,1 N. Sulejmani,1 S. Davis.1,2

    1Henry Ford Hospital, Detroit; 2Wayne State University, Detroit, MI.

    Introduction:Isavuconazole (ISV) is a triazole antifungal that is often utilized in solid organ transplant recipients (SOTR) for the treatment of invasive aspergillosis and mucormycosis. Isavuconazole…
  • 2018 American Transplant Congress

    Defective Innate Immune Response to Opportunistic Pathogens in Cytomegalovirus-Infected Monocytes

    P. Sen, A. R. Wilkie, R. Fernandes, R. J. Lane, S. E. Hickman, T. K. Means, E. R. Rosenberg, D. M. Coen, J. A. Fishman, J. El Khoury.

    Transplant and Immunocompromised Group, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; Department of Biological Chemistry and Pharmacology, Harvard Medical School, Boston, MA.

    Human cytomegalovirus (CMV) is the most common infection encountered in transplantation and is an important cause of morbidity and mortality in both solid organ and…
  • 2018 American Transplant Congress

    Therapeutic Drug Monitoring (TDM) of Suspension (SUS), Extended-Release (ER), and Intravenous (IV) Posaconazole (POS) at a Large Transplant Center

    G. Haidar, R. Shields, C. Clancy, M. Nguyen.

    Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.

    Background: Data on ER and IV POS among organ transplant recipients (OTRs) are limited, and the role of TDM is unclear.Methods: Retrospective study of patients…
  • 2018 American Transplant Congress

    A Multi-Center Analysis of Risk Factors for Pneumocystis Pneumonia (PCP) in Solid Organ Transplant Recipients

    S. Hosseini-Moghaddam, M. Shokoohi, G. Singh, S. Dufresne, A. Jevnikar, D. Kabbani, H. Cardinal, I. Houde, M-.J. Hebert, A. Shoker, G. Prasad, A. Humar, D. Kumar.

    Medicine, London Health Sciences Centre (LHSC), London, ON, Canada.

    Introduction: Pneumocystis pneumonia (PCP) is associated with morbidity and mortality in solid organ transplant patients (SOTs). There are increasing reports of late PCP in SOT…
  • 2018 American Transplant Congress

    Risk Factors for Invasive Fungal Infections among Lung Transplant Recipients

    K. Whitaker, J. Anesi, E. Blumberg, L. Gardo, J. Lee, M. Crespo, C. Bermudez, L. Glaser, M. Wilck.

    University of Pennsylvania, Philadelphia, PA.

    Objective: Lung transplant (LT) recipients are at high risk of invasive fungal infections (IFI) with an estimated 1-year incidence of 8%. Despite advances in antifungal…
  • 2018 American Transplant Congress

    Pneumocystis jiroveci Pneumonia (PJP) in Kidney and Pancreas Transplant Recipients in the Present Era of Routine Post-Transplant Prophylaxis: Risk Factors and Outcomes

    N. Garg, M. Jorgenson, M. Birschbach, J. Descourouez, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.

    University of Wisconsin, Madison.

    PJP after transplant (TX) is associated with substantial morbidity and mortality. In the present era of universal and routine implementation of PJP prophylaxis (PPX) during…
  • 2017 American Transplant Congress

    Diagnostic Bronchoscopy in Kidney Transplant Recipients with Acute Respiratory Failure: Risk or Value?

    D. Khadzhynov, J. Deissler, F. Halleck, L. Lehner, K. Budde, O. Staeck.

    Nephrology, Charité Universitaetsmedizin, Berlin, Germany

    Introduction:Few data evaluates the differential diagnostic value of bronchoalveolar lavages (FO-BAL) in kidney transplant recipients (KTR) with acute respiratory failure (ARF). We describe the results…
  • 2017 American Transplant Congress

    Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.

    P. Bryant,1 P. Pappas,1 C. Huisingh,1 R. Mannon,1 J. Locke,1 K. Wille,1 D. Eckhoff,1 J. Tallaj,1 J. Baddley.1,2

    1Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, AL; 2VAMC, Birmingham, AL

    Background: Cryptococcosis (crypto) is the third most common fungal infection in solid organ transplant (SOT) recipients. Although reduction of immunosuppression (IS) may improve patient outcomes…
  • 2017 American Transplant Congress

    MicroRNAs and Long Non-Coding RNAs as Potential Novel Biomarkers in Transplanted Patients with Candida Infection.

    A. Yang,1 C. Zhou,2 D. Li,3 W. Ju,1 Z. Guo,1 L. Wu,1 A. Hu,1 Y. Ma,1 D. Wang,1 X. Zhu,1 X. He.1

    1Organ Transplantation Center, The First Affiliated Hospital of Sun Yat -sen University, Guangzhou, Guangdong, China; 2Gastroenterology Unit, Massachusetts General Hospital, Boston, MA; 3Ophthalmology, Schepens Research Institute, Boston, MA

    There is an urgent need to develop sensitive and specific biomarkers for the early diagnosis of candida infection in transplanted patients. miRNAs and lncRNAs are…
  • 2017 American Transplant Congress

    Incidence of Fungal and Viral Infections Following Rituximab Use in Kidney Transplant Recipients.

    L. Wong, M. Ison, C. Richardson, K. Cunningham, C. D'Agostino, C. Tseng, A. Shetty.

    Northwestern Memorial Hospital, Chicago, IL

    Rituximab is used off-label in solid organ transplant for desensitization and treatment of antibody-mediated rejection (AMR). It targets CD20 and results in B cell depletion.…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences